Search research articles
Contact Us
Filters
Showing results (211-220 of 300) with videos related to
Page
of 30
Sort By:
Journal of the National Cancer Institute
|
January 2, 2017
Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations
Catherine S Diefenbach, Joseph M Connors, Jonathan W Friedberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2018
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)
Eileen P Smith, Hongli Li, Jonathan W Friedberg, et al.
Blood Advances
|
June 30, 2023
Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R
Rahul Lakhotia, Kieron Dunleavy, Jeremy S Abramson, et al.
Cancer Medicine
|
February 17, 2023
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis
Pallawi Torka, Levi D Pederson, Michael V Knopp, et al.
Leukemia & Lymphoma
|
May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816
Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
Blood
|
January 12, 2012
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database
Ann S LaCasce, Jonathan L Vandergrift, Maria A Rodriguez, et al.
Blood Advances
|
January 8, 2025
The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool
Matthew J Maurer, Susan K Parsons, Jenica N Upshaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2013
A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
British Journal of Haematology
|
October 12, 2013
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database
Makiko Ban-Hoefen, Ann Vanderplas, Allison L Crosby-Thompson, et al.
Cancer
|
April 8, 2014
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network
Alex F Herrera, Allison Crosby-Thompson, Jonathan W Friedberg, et al.
Page
of 30
Search research articles
Search
Showing results (211-220 of 300) with videos related to
Sort By:
Page
of 30
Journal of the National Cancer Institute
|
January 2, 2017
Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations
Catherine S Diefenbach, Joseph M Connors, Jonathan W Friedberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 1, 2018
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)
Eileen P Smith, Hongli Li, Jonathan W Friedberg, et al.
Blood Advances
|
June 30, 2023
Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R
Rahul Lakhotia, Kieron Dunleavy, Jeremy S Abramson, et al.
Cancer Medicine
|
February 17, 2023
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis
Pallawi Torka, Levi D Pederson, Michael V Knopp, et al.
Leukemia & Lymphoma
|
May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816
Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
Blood
|
January 12, 2012
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database
Ann S LaCasce, Jonathan L Vandergrift, Maria A Rodriguez, et al.
Blood Advances
|
January 8, 2025
The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool
Matthew J Maurer, Susan K Parsons, Jenica N Upshaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2013
A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
British Journal of Haematology
|
October 12, 2013
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database
Makiko Ban-Hoefen, Ann Vanderplas, Allison L Crosby-Thompson, et al.
Cancer
|
April 8, 2014
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network
Alex F Herrera, Allison Crosby-Thompson, Jonathan W Friedberg, et al.
Page
of 30